 BRIDGEWATER, N.J., Jan. 29, 2021 GLOBE NEWSWIRE -- VYNE Therapeutics Inc. Nasdaq: VYNE VYNE or the Company today announced that it has closed its previously announced registered direct offering of an aggregate of 21,097,046 shares of common stock at a purchase price of 2.37 per share. 